The Global Governance Office defines Novartis medical standards and ensures effective implementation across Novartis, in the following areas:
• External funding requests (Grants)
• Investigator Initiated Trials (IIT)
• Local and Regional Interventional Studies (LIS)
• Managed Access Programs (MAP)
• Non-interventional studies (NIS) incl. Registries & Post Approval Safety Studies (PASS)
• Patient Oriented Programs (POP)
• Post-Study Drug Supplies (PSDS)
• Research Collaborations and Consortiums (RCC)